American Pharmaceutical giant, Johnson & Johnson (J&J), announced yesterday that it was starting safe human trials with its COVID-19 vaccine after its study on monkeys showed that its best-performing vaccine candidate offered strong protection in a single dose. A published study in the journal, Nature, stated that during the conduct of the trials, when exposed to the virus, 6 out of 6 animals who were given the experimental vaccine were completely protected from lung disease. Also, 5 out of the 6 animals were protected from infection as measured by the presence of the virus in nasal swaps. The Chief Scientific Officer of J&J, Dr. Paul Stoffels, in a telephone conversation with Reuters said, ‘’ This gives us confidence that we can test a single-shot vaccine in this epidemic and learn whether it has a protective effect in humans.” J&J said that it had started early-stage human trials in the United States and Belgium and would test the experimental vaccin...
The best ideas, the simplest solutions, great results. This encapsulates what we offer in form of business, marketing and technoloy solutions, all geared towards improving your business processes and profitability.